Zhang et al., identified ADCK2 (AarF domain containing kinase 2), a mitochondrial kinase involved in regulating lipid metabolism and mitochondrial protein assembly, as a promising therapeutic target for NSCLC [27]. Here, ADCK2 is linked to non-small cell lung carcinoma.